MA H4532 | 2019-2020 | 191st General Court
Note: Replaces legislation H1703
Status
Spectrum: Moderate Partisan Bill (Democrat 19-3-1)
Status: Introduced on March 9 2020 - 25% progression, died in committee
Action: 2020-06-22 - Reporting date extended to Thursday December 31, 2020, pending concurrence
Pending: Joint Health Care Financing Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 9 2020 - 25% progression, died in committee
Action: 2020-06-22 - Reporting date extended to Thursday December 31, 2020, pending concurrence
Pending: Joint Health Care Financing Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Relative to opioid drug manufacturer assessments
Title
Relative to opioid drug manufacturer assessments
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2020-06-22 | House | Reporting date extended to Thursday December 31, 2020, pending concurrence |
| 2020-04-30 | Senate | Senate concurred |
| 2020-04-29 | House | Reporting date extended to Friday June 19, 2020, pending concurrence |
| 2020-03-26 | Senate | Senate concurred |
| 2020-03-23 | House | Reporting date extended to Friday May 1, 2020, pending concurrence |
| 2020-03-09 | House | Reported favorably by committee and referred to the Joint Committee on Health Care Financing |
| 2020-03-09 | House | New draft of H1703 |
| 2020-03-09 | House | Reported from the committee on Mental Health, Substance Use and Recovery |
Same As/Similar To
H1703 (Replaces) 2020-03-09 - Accompanied a new draft, see H4532
Massachusetts State Sources
| Type | Source |
|---|---|
| Summary | https://malegislature.gov/Bills/191/H4532 |
| Text | https://malegislature.gov/Bills/191/H4532.pdf |
